What is the appropriate Lasilactone (furosemide/spironolactone) tablet dose for a 26‑kg boy with an extra‑axial hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lasilactone Dosing for Extra-Axial Hemorrhage in a 26 kg Child

Lasilactone is not indicated for extra-axial hemorrhage, and standard pediatric dosing for this combination product does not exist in FDA labeling or guidelines—you should prescribe furosemide and spironolactone separately if diuresis is needed for cerebral edema management.

Critical Context Issue

The evidence provided focuses almost entirely on ascites in cirrhosis and heart failure—not intracranial hemorrhage or cerebral edema. Extra-axial hemorrhage (subdural, epidural, or subarachnoid bleeding) requires entirely different management principles focused on:

  • Intracranial pressure (ICP) control
  • Surgical evacuation when indicated
  • Neuroprotection
  • Avoiding hypovolemia and electrolyte disturbances that worsen outcomes

Why Lasilactone is Problematic Here

Lasilactone is a fixed-dose combination containing:

  • Furosemide 20 mg + Spironolactone 50 mg per capsule 1

This fixed ratio creates several problems:

  1. No pediatric dosing exists for this combination product in neurological conditions
  2. The ratio is inappropriate for ICP management (spironolactone offers minimal benefit for cerebral edema)
  3. Risk of hypovolemia from aggressive loop diuretic use can worsen cerebral perfusion
  4. Electrolyte disturbances (particularly hyponatremia) can exacerbate cerebral edema and worsen neurological outcomes 2

If Diuresis is Truly Needed (Rare in Extra-Axial Hemorrhage)

Recent evidence suggests furosemide has minimal ICP-lowering efficacy and significant cognitive side effects. A 2025 randomized trial in IIH patients showed furosemide reduced ICP by only -3.0 mmHg with common adverse effects 3.

Furosemide Monotherapy (if prescribed):

  • Initial dose: 1 mg/kg/dose IV or PO 4
  • For 26 kg child: 26 mg as single dose
  • Titration: May increase by 1-2 mg/kg every 6-8 hours if inadequate response
  • Maximum: 6 mg/kg/day (156 mg/day for this child) 4

Critical Monitoring:

  • Serum sodium (hyponatremia <125 mmol/L worsens cerebral edema and outcomes) 5, 6
  • Volume status (hypovolemia reduces cerebral perfusion pressure)
  • Potassium (hypokalemia increases risk)
  • Renal function

What You Should Actually Consider

For extra-axial hemorrhage with elevated ICP:

  1. Hypertonic saline (3% NaCl) is first-line for osmotherapy
  2. Mannitol 0.25-1 g/kg IV for acute ICP crises
  3. Neurosurgical consultation for evacuation criteria
  4. Avoid aggressive diuresis that compromises cerebral perfusion pressure (CPP = MAP - ICP)

Common Pitfalls

  • Using diuretics reflexively for any brain injury without clear indication
  • Inducing hyponatremia with loop diuretics, which paradoxically worsens cerebral edema
  • Compromising cerebral perfusion through excessive volume depletion
  • Using fixed-combination products when individual agent titration is needed

The evidence base you're working from addresses the wrong clinical condition entirely. If this child has symptomatic cerebral edema from extra-axial hemorrhage requiring medical management, consult neurosurgery and use evidence-based osmotherapy rather than diuretics designed for volume overload states.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.